Europe Bovine Respiratory Disease Treatment Market By Type Of Treatment (Anti-Infectious Agents (antibiotics And Sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatories, And Mucolytic), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Europe Bovine Respiratory Disease Treatment Market By Type Of Treatment (Anti-Infectious Agents (antibiotics And Sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatories, And Mucolytic), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 910 | Pages: 142 | October 2018 | Region: Europe


The Europe Bovine Respiratory Disease Treatment Market has been estimated at USD 9.18 million in 2018 and is projected to reach USD 23.34 million by 2023, at a CAGR of 20.5% during the forecast period from 2018 to 2023. There is a huge influence of bovine respiratory disease (BRD), diarrhoea, arthritis and otitis on the economically significant parameters of mortality, hot carcass weight (HCW), carcass quality, fat cover and meat colour which produces problem for the cattle production.

BRD is a complex multi-factorial disease that involves an interaction between several factors. In the current scenario body temperature has been used to determine whether treatment should be done or not. Body temperature is such an important diagnostic test that many feedlots will treat animals based upon an undifferentiated fever. 

A combination of disease organisms is usually accountable for the respiratory infection and illness, but other factors also affect the animal’s health. Environmental factors, particularly transport, have been associated with BRD; weather has always been implicated in the occurrence of the disease. It has been concluded that stressful events, and others like calving or an overenthusiastic introduction to high grain rations, may precipitate cases of BRD.

The Europe bovine respiratory disease treatment market has been segmented on the basis of type of treatment into anti-infectious agents, anti-parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment. Geographically Europe market is segmented into France, Italy, Spain, Germany and UK.

The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       

                                                5.1.1.1 Antibiotics           

                                                5.1.1.2 Sulfas    

                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                                6.1 Introduction                              

                                6.2 U.K                

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Bovine Respiratory Disease Treatment Market By Region, From 2018–2023 (USD Million)
  2. Europe Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  3. Europe Anti-Infectious Agents Market By Region, From 2018–2023 (USD Million)
  4. Europe Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  5. Europe Antibiotics Market By Region, From 2018–2023 (USD Million)
  6. Europe Sulfas Market By Region, From 2018–2023 (USD Million)
  7. Europe Anti-Parasiticides Market By Region, From 2018–2023 (USD Million)
  8. Europe Bronchodilators Market By Region, From 2018–2023 (USD Million)
  9. Europe Oral Rehydration Fluids Market By Region, From 2018–2023 (USD Million)
  10. Europe Non-Steroidal Anti-Inflammatories Market By Region, From 2018–2023 (USD Million)
  11. Europe Mucolytic Market By Region, From 2018–2023 (USD Million)
  12. U.K Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  13. U.K Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  14. Spain Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  15. Spain Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  16. Germany Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  17. Germany Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  18. Italy Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  19. Italy Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  20. France Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  21. France Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
UK Pet Insurance Market By Policy Type (Lifetime Cover (Accident Cover, Illness Cover), Non-Lifetime Cover (Accident Cover, Illness Cover), Others), By Policy (Dog Insurance, Cat Insurance, Rabbit Insurance, Horse I...
Middle East And Africa Pet Insurance Market By Policy Type (Lifetime Cover (Accident Cover, Illness Cover), Non-Lifetime Cover (Accident Cover, Illness Cover), Others), By Policy (Dog Insurance, Cat Insurance, Rabbi...
Latin America Pet Insurance Market by Policy Type (Lifetime Cover (Accident Cover, Illness Cover), Non-Lifetime Cover (Accident Cover, Illness Cover), Others), by Policy (Dog Insurance, Cat Insurance, Rabbit Insuran...
Asia Pacific Pet Insurance Market By Policy Type (Lifetime Cover (Accident Cover, Illness Cover), Non-Lifetime Cover (Accident Cover, Illness Cover), Others), By Policy (Dog Insurance, Cat Insurance, Rabbit Insuranc...
Europe Pet Insurance Market By Policy Type (Lifetime Cover (Accident Cover, Illness Cover), Non-Lifetime Cover (Accident Cover, Illness Cover), Others), By Policy (Dog Insurance, Cat Insurance, Rabbit Insurance, Hor...
North America Pet Insurance Market By Policy Type (Lifetime Cover (Accident Cover, Illness Cover), Non-Lifetime Cover (Accident Cover, Illness Cover), Others), By Policy (Dog Insurance, Cat Insurance, Rabbit Insuran...
Pet Insurance Market By Policy Type (Lifetime Cover (Accident Cover, Illness Cover), Non-Lifetime Cover (Accident Cover, Illness Cover), Others), By Policy (Dog Insurance, Cat Insurance, Rabbit Insurance, Horse Insu...
Latin America Veterinary Hematology Analyzers Market By Product (Table Top Analyzers, Point Of Care Analyzers), By Analysis Parameter (2 Part WBC Differential, 3 Part WBC Differential, 5 Part WBC Differential, And O...
Asia Pacific Veterinary Hematology Analyzers Market By Product (Table Top Analyzers, Point Of Care Analyzers), By Analysis Parameter (2 Part WBC Differential, 3 Part WBC Differential, 5 Part WBC Differential, And Ot...
Europe Veterinary Hematology Analyzers Market By Product (Table Top Analyzers, Point Of Care Analyzers), By Analysis Parameter (2 Part WBC Differential, 3 Part WBC Differential, 5 Part WBC Differential, And Others),...
North America Veterinary Hematology Analyzers Market By Product (Table Top Analyzers, Point Of Care Analyzers), By Analysis Parameter (2 Part WBC Differential, 3 Part WBC Differential, 5 Part WBC Differential, And O...
Veterinary Hematology Analyzers Market Segmented By Product, By Analysis Parameter, By End User, And By Region - Global Growth, Trends, And Forecast To 2024...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.